BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38288904)

  • 1. SIRT7 promotes Hippo/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1.
    Gu Y; Ding C; Yu T; Liu B; Tang W; Wang Z; Tang X; Liang G; Peng J; Zhang X; Li Z
    Cancer Sci; 2024 Apr; 115(4):1209-1223. PubMed ID: 38288904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
    Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
    J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway.
    Shu B; Zhou Y; Lei G; Peng Y; Ding C; Li Z; He C
    Cancer Sci; 2024 May; 115(5):1476-1491. PubMed ID: 38475938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma.
    Kim W; Khan SK; Liu Y; Xu R; Park O; He Y; Cha B; Gao B; Yang Y
    Gut; 2018 Sep; 67(9):1692-1703. PubMed ID: 28866620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
    Wong KF; Liu AM; Hong W; Xu Z; Luk JM
    Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.
    Lin C; Yao E; Chuang PT
    Dev Biol; 2015 Jul; 403(1):101-13. PubMed ID: 25912685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation.
    Cheng JC; Wang EY; Yi Y; Thakur A; Tsai SH; Hoodless PA
    Mol Cancer Res; 2018 Oct; 16(10):1543-1555. PubMed ID: 29903770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
    Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
    J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated hippo signal pathway inhibits cell proliferation and promotes apoptosis in NK/T cell lymphoma cells.
    Chang Y; Fu XR; Cui M; Li WM; Zhang L; Li X; Li L; Sun ZC; Zhang XD; Li ZM; You XY; Nan FF; Wu JJ; Wang XH; Zhang MZ
    Cancer Med; 2019 Jul; 8(8):3892-3904. PubMed ID: 31124291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
    Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
    Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2E1-dependent upregulation of SIRT7 is response to alcohol mediated metastasis in hepatocellular carcinoma.
    Zhang C; Zhao J; Zhao J; Liu B; Tang W; Liu Y; Huang W; Weinman SA; Li Z
    Cancer Gene Ther; 2022 Dec; 29(12):1961-1974. PubMed ID: 35902730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal dehydrogenase 5 (RHD5) attenuates metastasis via regulating HIPPO/YAP signaling pathway in Hepatocellular Carcinoma.
    Hu H; Xu L; Luo SJ; Xiang T; Chen Y; Cao ZR; Zhang YJ; Mo Z; Wang Y; Meng DF; Yu L; Lin LZ; Zhang SJ
    Int J Med Sci; 2020; 17(13):1897-1908. PubMed ID: 32788868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of high-mobility group box-1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling-deficient mice.
    Athavale D; Song Z; Desert R; Han H; Das S; Ge X; Komakula SSB; Chen W; Gao S; Lantvit D; Guzman G; Nieto N
    Hepatol Commun; 2022 Aug; 6(8):2155-2169. PubMed ID: 35344292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ.
    Hao X; Zhang Y; Shi X; Liu H; Zheng Z; Han G; Rong D; Zhang C; Tang W; Wang X
    J Exp Clin Cancer Res; 2022 Sep; 41(1):281. PubMed ID: 36131287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.
    Ni W; Zhang Y; Zhan Z; Ye F; Liang Y; Huang J; Chen K; Chen L; Ding Y
    J Hematol Oncol; 2017 Apr; 10(1):91. PubMed ID: 28420424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway.
    Yang J; Zhang X; Liu L; Yang X; Qian Q; Du B
    Life Sci; 2021 Jan; 264():118711. PubMed ID: 33186566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 20. Decursin inhibits the growth of HepG2 hepatocellular carcinoma cells via Hippo/YAP signaling pathway.
    Li J; Wang H; Wang L; Tan R; Zhu M; Zhong X; Zhang Y; Chen B; Wang L
    Phytother Res; 2018 Dec; 32(12):2456-2465. PubMed ID: 30251417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.